Search Result "Mcl-1."
Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer
Journal: Current Molecular Medicine
Volume: 8 Issue: 2 Year: 2008 Page: 138-147
Author(s): Gordon C. Shore, Matthew R. Warr
Effects of Natural Products on Mcl-1 Expression and Function
Journal: Current Medicinal Chemistry
Volume: 22 Issue: 30 Year: 2015 Page: 3447-3461
Author(s): Florian Muller,Claudia Cerella,Flavia Radogna,Mario Dicato,Marc Diederich
Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 40 Year: 2017 Page: 4488-4514
Author(s): Mohammad Abid,Yogesh A. Sonawane,Jacob I. Contreras,Sandeep Rana,Amarnath Natarajan
Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents
Journal: Current Molecular Medicine
Volume: 21 Issue: 5 Year: 2021 Page: 426-439
Author(s): Xing Lu,Hong Liang,Chris Orvig,Zhen-Feng Chen
Synthesis, Anticancer Evaluation and Molecular Docking of HexahydroquinolineDerivatives as Mcl-1 Inhibitors and Apoptosis Inducers
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 11 Year: 2022 Page: 2142-2155
Author(s): Ashlesha Chauhan,Subhas S. Karki,Nishith Teraiya
Recent Advances in the Development of Selective Mcl-1 Inhibitors for the Treatment of Cancer (2017-Present)
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 15 Issue: 4 Year: 2020 Page: 306-320
Author(s): Ying Fan,Xuben Hou,Hao Fang
QSAR Analysis and Molecular Docking Studies of Aryl Sulfonamide Derivatives as Mcl-1 Inhibitors and the Influence of Structure and Chirality on the Inhibitory Activity
Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 16 Year: 2024 Page: 3465-3478
Author(s):
Small-molecule High-throughput Screening Identifies an MEK InhibitorPD198306 that Enhances Sorafenib Efficacy via MCL-1 and BIM inHepatocellular Carcinoma Cells
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 26 Issue: 7 Year: 2023 Page: 1364-1374
Author(s):
State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 28 Year: 2012 Page: 4875-4884
Author(s): G. Zauli,R. Voltan,V. Tisato,P. Secchiero
Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins
Journal: Current Drug Targets
Volume: 11 Issue: 6 Year: 2010 Page: 699-707
Author(s): David Karnak, Liang Xu